Grifols (GIFLF) Gross Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Grifols (GIFLF) Gross Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 484.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 96.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -93.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -91.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 210.00 |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 1,966.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | -475.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -553.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -1,260.00 |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -74.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -74.00 |
| Dec 31, 2021 | 693.00 |
| Dec 31, 2020 | -7,839.00 |
| Mar 31, 2020 | 7.00 |
| Dec 31, 2019 | -57.00 |
| Mar 31, 2019 | -214.00 |
| Dec 31, 2018 | -337.00 |
| Jun 30, 2018 | -248.00 |
| Mar 31, 2018 | -326.00 |
| Dec 31, 2017 | 2,454.00 |
| Jun 30, 2017 | 187.00 |
| Mar 31, 2017 | -3,202.00 |
| Dec 31, 2016 | -2,333.00 |
| Sep 30, 2016 | -290.00 |
| Jun 30, 2016 | -18.00 |
| Mar 31, 2016 | 3,340.00 |
| Dec 31, 2015 | 3,091.00 |
| Sep 30, 2015 | -192.00 |
| Jun 30, 2015 | -234.00 |
| Mar 31, 2015 | -306.00 |